Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-30

Clinical Trial Update: Effect of Low-Dose Oral Minoxidil as Treatment of Permanent Chemotherapy-Induced Alopecia [EARLY_Phase 1]

View source ↗

Summary

Early-phase 1 clinical trial evaluating low-dose oral minoxidil as a treatment for permanent chemotherapy-induced alopecia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MINOXIDIL (Minoxidil)

Snippet

Sponsor: Northwestern University | Conditions: Permanent Chemotherapy-induced Alopecia | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING